InvestorsHub Logo
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

Re: None

Friday, 03/31/2017 1:23:35 PM

Friday, March 31, 2017 1:23:35 PM

Post# of 23979
GALT: Other NASH play BLRX @ .90s.

BioLineRX did a $25M secondary today that sent the stock to .90s.

The great move in GALT is a set-up for BLRX now that the secondary is out of the way and BLRX is flush.

Novartis is the BLRX partner on the NASH liver drug.

Link:
http://www.fiercebiotech.com/biotech/novartis-partner-biolinerx-licenses-nash-drug-after-joint-evaluation

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.